BRUKER CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
BRUKER CORPORATION (BRKR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -2.00% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2016-02-29
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2015 was -2.00%, a 120.83% decline from fiscal 2014.
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2014 was 9.60%, a 20.00% decline from fiscal 2013.
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2013 was 12.00%, a 35.83% decline from fiscal 2012.
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2012 was 18.70%, a 46.09% increase from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2015-12-31 | -2.00% 10-K · filed 2016-02-29 | |
| 2014-12-31 | 9.60% 10-K · filed 2016-02-29 | |
| 2013-12-31 | 12.00% 10-K · filed 2016-02-29 | |
| 2012-12-31 | 18.70% 10-K · filed 2015-02-27 | |
| 2011-12-31 | 12.80% 10-K · filed 2014-02-27 | 0.30% 10-K · filed 2012-02-29 |
| 2010-12-31 | 13.70% 10-K · filed 2013-02-28 | 1.80% 10-K · filed 2012-02-29 |
| 2009-12-31 | 3.00% 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |